ANAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

AnaptysBio (ANAB) Earnings Date & Reports

AnaptysBio Inc is a clinical-stage biotechnology company... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ANAB is expected to report earnings to rise 8.59% to -138 cents per share on August 11

Q2'25

Est.

$-1.39

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.90

Q3'24

Beat

by $0.56

Q2'24

Missed

by $0.67

The last earnings report on May 05 showed earnings per share of -127 cents, beating the estimate of -129 cents. With 73.33K shares outstanding, the current market capitalization sits at 602.89M.

View a ticker or compare two or three

Compare

ANAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ANAB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ANAB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10770 Wateridge Circle

Phone

+1 858 362-6295

Employees

117

Web

https://www.anaptysbio.com